A Medical Device Daily
Natus Medical (San Carlos, California) reported that Roth Capital Partners, the sole underwriter of its recently disclosed public offering of 770,000 shares of common stock valued at roughly $13.4 million (Medical Device Daily, April 7, 2008), has exercised its over-allotment option. Roth will purchase another 115,500 shares, bringing thtotal shares offered to 885,500 and the expected proceeds to $15.4 million based on a per share price of $18.27.
The offering closed on Wednesday. The company expects to receive about $15.4 million in net proceeds from the offering, after payment of underwriting discounts and expenses of the offering.
Natus is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care.